1H-LSD
Pharmaceutical compound
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
Chemical and physical data | |
Formula | C26H35N3O2 |
Molar mass | 421.585 g·mol−1 |
3D model (JSmol) | |
| |
|
1H-LSD (N1-hexanoyl-lysergic acid diethylamide, SYN-L-027)[1] is an acylated derivative of lysergic acid diethylamide (LSD), with a six carbon hexanoyl chain attached to the N1 position. It acts as a prodrug for LSD, and in animal studies produces drug-appropriate responding with a similar potency to short-chain homologues such as ALD-52 and 1P-LSD, in contrast to the 4 and 5 carbon homologues 1B-LSD and 1V-LSD which are several times weaker.[2]
See also
[edit]References
[edit]- ^ WO 2024028495, Stratford A, Williamson JP, "Prodrugs of Substituted Ergolines", published 8 February 2024, assigned to Synex Holdings BV
- ^ Brandt SD, Kavanagh PV, Gare S, Stratford A, Halberstadt AL (July 2024). "Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD)" (PDF). Drug Testing and Analysis. doi:10.1002/dta.3767. PMID 38965834.
Ergolines (incl. lysergines) |
|
---|---|
Clavines (6,8-dimethylergolines) | |
Lysergamides (lysergic acid amides) |
|
Ergopeptines (peptide ergolines) |
|
Partial ergolines |
|
Related compounds | |
Natural sources |
|
|
![]() | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=1H-LSD&oldid=1284988798"